The main theme of the report is the analysis of global data on deals, funding, and market exits of private companies in the field of artificial intelligence.
Key findings include: 55% of new AI unicorns are focused on healthcare. Out of 11 companies that reached a valuation of $1B+, 6 are concentrated on healthcare applications. Among the 85 largest AI mergers and acquisitions deals, 3 were related to AI agent technologies. AI funding in Q1’25 reached a record $66.6B, up 51% from Q4’24, with significant contributions from large funding rounds such as $40B from OpenAI.